Asli Sahin

Dr. Asli Sahin is a dedicated member of AbbVie's S&E Neuroscience Team with over a decade of experience in molecular neuroscience.

Her academic journey includes a PhD from Brown University and postdoctoral work at Harvard, specializing in molecular biology, cell biology, and biochemistry.

Prior to her current role, Dr. Sahin contributed to Allergan's External Science and Innovation Team and participated in Abbvie's Strategy Leadership Program, focusing on strategic opportunities for in-licensing clinical assets, co-marketing partnerships, and acquisitions in CNS disorders.

Her expertise extends to providing consulting services in immuno-oncology, digital health, clinical trials, vaccines, diagnostic imaging, drug repositioning, and gene delivery platforms.

Dr. Sahin's educational background includes studies in molecular biology, genetics, and mathematics, with degrees from leading institutions such as Brown University and Boğaziçi Üniversitesi.

She has held various positions including Associate Director at AbbVie, Senior Researcher at Allergan, and roles at Harvard Graduate Volunteer Consulting Group and Massachusetts General Hospital.

Dr. Sahin's valuable experience and strategic insights make her a formidable biotech strategist in the field of neuroscience.